Meir Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2023

  1. Anti-angiogenic agents for NSCLC following first-line immunotherapy: Rationale, recent updates, and future perspectives

    Lung Cancer, Vol. 179

2020

  1. Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?

    Lung Cancer, Vol. 144, pp. 76-84